A man who was left brain-dead after suffering serious side effects during a drug trial in France died on Sunday, according to the hospital which had been treating him.
The CEO of the Portuguese pharmaceutical company that was developing the drug said he was “profoundly shocked” by the death and pledged an investigation.
Five other volunteers hospitalized a week ago when the drug trial went wrong were “in a stable condition,” Rennes University Hospital said in a statement.
Photo: AP
France-based private laboratory Biotrial was testing a new pain and mood disorder medication on humans for pharmaceutical Bial, in what is known as a phase 1 trial, to test the drug’s safety.
A total of 108 volunteers took part in the trial, 90 of whom received the drug at varying doses, while the rest were given placebos.
The six men who were hospitalized, aged 28 to 49, were the group which received the highest dose.
Bial CEO Antonio Portela said he was “profoundly shocked by the situation,” according to Portugal’s Lusa news agency.
“On my behalf and the behalf of Bial, I would like to express my deepest apologies to the family of the volunteer who died after participating in the Phase I trial of our experimental molecule,” he added.
Portela said Bial staff in France and Portugal were “working tirelessly to understand the causes of this accident.”
Rennes University Hospital head of neurology Pierre-Gilles Edan on Friday said that three of the men were suffering a “handicap that could be irreversible” and another also had neurological problems.
The sixth volunteer had no symptoms, but was being monitored.
“The 84 other volunteers exposed to the drug” have been contacted, the hospital said, adding that 10 of them were examined and did not have the “anomalies” seen in the hospitalized patients.
The incident is the worst of its kind ever to have taken place in France, which has launched three separate probes to determine whether the tragedy was caused by an error in the trial’s procedures or in the substance tested.
Bial is cooperating with the investigation and vows it followed “international best practice” in developing the drug.
Biotrial on Sunday said in a statement that it planned to work with the international scientific community to develop “changes to the standards governing such trials,” without giving further details.
The company, which has been carrying out drug trials on behalf of pharmaceutical companies since 1989, said the situation is “even more upsetting given that there is as yet no explanation.”
Previous testing, notably on animals, had not generated unusual results.
Such serious mishaps are rare during the development of a drug, which begins in the laboratory before being animal tested and then three phases of human trials before it can be brought to market.
French public body ONIAM, which is responsible for compensating the victims of medical accidents, said it had in its files only about 10 cases of accidents during drug trials over the past 15 years, and “with consequences infinitely less serious” than the case in Rennes.
Although a rarity, there have been precedents in other countries.
A comparable accident took place in 2006 in London when six people taking German drug manufacturer TeGenero’s TGN1412, which it was developing to treat certain types of cancer and other immunological diseases, fell seriously ill, with one suffering from multiple organ failure.
Two of the volunteers were in critical condition and one lost all his fingers and toes. The victims said they had the impression that their brains were on fire and that their eyes were coming out of their sockets.
Although they all survived, experts said at the time that their immune systems would be damaged for life.
Chinese President Xi Jinping (習近平) is to visit Russia next month for a summit of the BRICS bloc of developing economies, Chinese Minister of Foreign Affairs Wang Yi (王毅) said on Thursday, a move that comes as Moscow and Beijing seek to counter the West’s global influence. Xi’s visit to Russia would be his second since the Kremlin sent troops into Ukraine in February 2022. China claims to take a neutral position in the conflict, but it has backed the Kremlin’s contentions that Russia’s action was provoked by the West, and it continues to supply key components needed by Moscow for
Japan scrambled fighter jets after Russian aircraft flew around the archipelago for the first time in five years, Tokyo said yesterday. From Thursday morning to afternoon, the Russian Tu-142 aircraft flew from the sea between Japan and South Korea toward the southern Okinawa region, the Japanese Ministry of Defense said in a statement. They then traveled north over the Pacific Ocean and finished their journey off the northern island of Hokkaido, it added. The planes did not enter Japanese airspace, but flew over an area subject to a territorial dispute between Japan and Russia, a ministry official said. “In response, we mobilized Air Self-Defense
CRITICISM: ‘One has to choose the lesser of two evils,’ Pope Francis said, as he criticized Trump’s anti-immigrant policies and Harris’ pro-choice position Pope Francis on Friday accused both former US president Donald Trump and US Vice President Kamala Harris of being “against life” as he returned to Rome from a 12-day tour of the Asia-Pacific region. The 87-year-old pontiff’s comments on the US presidential hopefuls came as he defied health concerns to connect with believers from the jungle of Papua New Guinea to the skyscrapers of Singapore. It was Francis’ longest trip in duration and distance since becoming head of the world’s nearly 1.4 billion Roman Catholics more than 11 years ago. Despite the marathon visit, he held a long and spirited
China would train thousands of foreign law enforcement officers to see the world order “develop in a more fair, reasonable and efficient direction,” its minister for public security has said. “We will [also] send police consultants to countries in need to conduct training to help them quickly and effectively improve their law enforcement capabilities,” Chinese Minister of Public Security Wang Xiaohong (王小洪) told an annual global security forum. Wang made the announcement in the eastern city of Lianyungang on Monday in front of law enforcement representatives from 122 countries, regions and international organizations such as Interpol. The forum is part of ongoing